Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » News » Blog article: De Niro Beats Prostate Cancer Suit

De Niro Beats Prostate Cancer Suit

This Article was Written March 14th, 2008

Powered by Gregarious (39)

A Los Angeles judge on Tuesday granted the actor’s request to toss a lawsuit filed against him by an insurance company that claimed De Niro intentionally withheld that he had prostate cancer before the insurer signed on to cover one of his films.
Fireman’s Fund Insurance Co. insured the production of 2003’s Hide and Seek, in which De Niro plays a mentally unraveling widower whose daughter, played by Dakota Fanning, takes solace in an evil imaginary friend.

Fireman’s Fund sued the Raging Bull star in October 2006, contending he wrongfully checked off a box indicating he had “never been diagnosed with or treated for” various conditions, including a diseased prostate, when he filled out his medical certificate.

Per the complaint, the company ended up shelling out $1.8 million to cover the cost of production delays incurred when De Niro had to take time out for treatment. (The now 64-year-old actor underwent surgery at New York’s Memorial Sloan-Kettering Cancer Center in December 2003 and has long since reportedly been cancer-free.)

In a motion to get the case thrown out, De Niro maintained he underwent a biopsy three days before and received his diagnosis two days after he completed the insurance documentation.

“This ruling vindicates what we’ve said all along: Mr. De Niro answered Fireman’s Fund’s questions truthfully and we are pleased that the Court has found that Fireman’s Fund can’t sue Mr. De Niro for getting cancer,” attorney Robyn C. Crowther said in a statement.

Additional court dates concerning the case have been wiped from the docket, according to the judge’s minute order.

This is an E! Online story written by By Natalie Finn on Tue, 11 Mar 2008

For information comparing surgery and other prostate cancer treatment options, visit www.cesium131.com.

Powered by Gregarious (39)

Share This Post - instructions included

PLEASE post a comment below

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    Green Tea Component May Slow Prostate Cancer

  • Green Tea Component May Slow Prostate Cancer Men in small study took capsules equivalent to brewed beverage Friday, June 19 (HealthDay News) -- The active compounds in green tea might slow the progression of prostate cancer, the results of a small study suggest. The study included 26 men, 41 to 72 years old,

    • Newest isotope used in brachytherapy for prostate cancer

  • FOR IMMEDIATE RELEASE: July 20, 2007 Scientific abstracts on the newest isotope used in brachytherapy for prostate cancer--IsoRay Medical’s Proxcelan™ with Cesium-131--presented at the American Association of Physicists in Medicine (AAPM) annual conference, July 22-26 RICHLAND, Washington - Noted medical researchers from around the country will gather at the

    • 5 Ways to Reduce the Risk of Prostate Cancer

  • Prostate cancer is one of the leading killers of men. The National Cancer Institute estimates that 186,320 men will be diagnosed with prostate cancer this year, and 28,660 will die from it. Although it’s one of the most common cancers suffered by men, there are ways to minimize the risk

    • Molecular Fingerprints Point The Way To Earlier Cancer Diagnosis And More Targeted Treatment

  • Molecular Fingerprints Point The Way To  Earlier Cancer Diagnosis And More Targeted Treatment ScienceDaily (Mar. 23, 2009) — Metabolites are molecular fingerprints of what your cells are up to and Dr. Arun Sreekumar wants to know the impression made by cancer.   You've likely heard about metabolites; your physician probably screens for some known ones

    • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading

  • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading ScienceDaily (Feb. 12, 2009) — Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading. In experiments reported in the journal Nature, the

    • Prostate Cancer Most Common Cause of Cancer Deaths in Jamaican Men

  • Prostate cancer is the most common cause of cancer deaths in Jamaican men. If caught at an early, localised stage, prostate cancer is curable. Even advanced cancer can be treated with drugs made more available under the National Health Fund.Yet, it is estimated that 40 per cent of men with

    • Stereotactic Radiotherapy ''Promising'' For Early Prostate Cancer

  • Stereotactic Radiotherapy ''Promising'' For Early Prostate Cancer Last Updated: 2009-03-23 8:00:11 -0400 (Reuters Health)NEW YORK (Reuters Health) - The results of a small phase II trial suggest that stereotactic body radiotherapy (SBRT), which involves a higher dose but shorter course than standard external beam radiotherapy, is a safe and effective treatment for

    • Urologic Oncology Institute Launched To Offer Multi-Disciplinary Care, Personalized Treatments To Patients

  • Urologic Oncology Institute Launched To  Offer Multi-Disciplinary Care, Personalized Treatments To Patients UCLA has launched a first-of-its-kind, patient-centered institute dedicated to developing leading-edge therapies for the treatment of kidney, bladder, testicular and prostate cancers. The Institute of Urologic Oncology at UCLA challenges the traditional model of academic departments operating independently of each other,

    • Caution Advised When Using Hormone Therapy for Prostate Cancer

  • In men with localized but aggressive prostate cancer, the combination of testosterone-lowering therapy and radiation improves survival substantially more than radiation therapy alone. But testosterone-lowering therapy isn’t so hot for the heart, reports the April issue of the Harvard Heart Letter. Low testosterone can increase harmful LDL cholesterol, blood sugar,

    • Doctors rethink treatment for prostate cancer in older men

  • With increasing life expectancies, improved surgical tools and better information on patient results, many older men diagnosed with early prostate cancer are taking a pass on the traditional advice to hold off on treatment for a period of time. Such "watchful waiting" - or closely monitoring the cancer's progression - is


  •  

    July 2010
    M T W T F S S
    « Jan    
     1234
    567891011
    12131415161718
    19202122232425
    262728293031  
images